Niagen Bioscience, Inc. (NAGE)
3.17
+0.06
(+1.93%)
USD |
NASDAQ |
Sep 04, 16:00
3.16
-0.01
(-0.32%)
After-Hours: 20:00
Niagen Bioscience Debt to Equity Ratio : 0.0282 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0282 |
| March 31, 2026 | 0.0313 |
| December 31, 2025 | 0.0368 |
| September 30, 2025 | 0.0432 |
| June 30, 2025 | 0.0513 |
| March 31, 2025 | 0.0637 |
| December 31, 2024 | 0.0575 |
| September 30, 2024 | 0.0842 |
| June 30, 2024 | 0.1017 |
| March 31, 2024 | 0.1114 |
| December 31, 2023 | 0.1152 |
| September 30, 2023 | 0.1388 |
| June 30, 2023 | 0.1451 |
| March 31, 2023 | 0.1459 |
| December 31, 2022 | 0.1485 |
| September 30, 2022 | 0.2084 |
| June 30, 2022 | 0.2185 |
| March 31, 2022 | 0.1801 |
| December 31, 2021 | 0.1482 |
| September 30, 2021 | 0.0944 |
| June 30, 2021 | 0.0833 |
| March 31, 2021 | 0.0335 |
| December 31, 2020 | 0.0997 |
| September 30, 2020 | 0.0937 |
| June 30, 2020 | 0.0609 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0932 |
| December 31, 2019 | 0.0841 |
| September 30, 2019 | 0.0738 |
| June 30, 2019 | 0.8098 |
| March 31, 2019 | 0.1086 |
| December 31, 2018 | 0.0114 |
| September 30, 2018 | 0.0108 |
| June 30, 2018 | 0.0101 |
| March 31, 2018 | 0.0098 |
| December 31, 2017 | 0.0094 |
| September 30, 2017 | 0.0163 |
| June 30, 2017 | 0.0269 |
| March 31, 2017 | 0.0684 |
| December 31, 2016 | 0.0601 |
| September 30, 2016 | 0.0422 |
| June 30, 2016 | 0.0447 |
| March 31, 2016 | 0.8387 |
| December 31, 2015 | 1.05 |
| September 30, 2015 | 1.278 |
| June 30, 2015 | 1.423 |
| March 31, 2015 | 0.8311 |
| December 31, 2014 | 0.7161 |
| September 30, 2014 | 0.1376 |
| June 30, 2014 | 0.1305 |
| March 31, 2014 | 0.0805 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cyanotech Corp. | 1.424 |
| Mannatech, Inc. | -1.330 |
| Natural Alternatives International, Inc. | 1.033 |
| USANA Health Sciences, Inc. | 0.00 |
| Nature's Sunshine Products, Inc. | 0.1266 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 106.59M |
| Total Liabilities (Quarterly) | 24.06M |
| Shareholders Equity (Quarterly) | 82.53M |
| Current Ratio | 6.497 |
| Net Debt Paydown Yield | 0.09% |